Skip to main content
. 2020 Jan;72(1):1–49. doi: 10.1124/pr.118.016899

Fig. 2.

Fig. 2.

Binding sites for β2-agonists revealed by crystal structures. (A) Crystal structures of human β2AR in complex with epinephrine (Supplemental Material 1-PDB ID 4LDO), BI-167107 (Supplemental Material 1-PDB ID 4LDE), and salmeterol (Supplemental Material 1-PDB ID 6MXT). Polar interactions are shown as dashed lines. Residues in β2AR that interact with each ligand are shown as sticks. (B) Exosite for the binding of the tail group of salmeterol in the crystal structure of human β2AR with salmeterol (Supplemental Material 1-PDB ID 6MXT).